News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
687,127 Results
Type
Article (39112)
Company Profile (282)
Press Release (647733)
Section
Business (203890)
Career Advice (1993)
Deals (35368)
Drug Delivery (88)
Drug Development (80835)
Employer Resources (168)
FDA (16100)
Job Trends (14806)
News (344613)
Policy (32447)
Tag
Academia (2530)
Alliances (49145)
Alzheimer's disease (1250)
Approvals (16035)
Artificial intelligence (143)
Bankruptcy (352)
Best Places to Work (11563)
Biotechnology (201)
Breast cancer (167)
Cancer (1287)
Cardiovascular disease (106)
Career advice (1661)
Cell therapy (267)
Clinical research (64562)
Collaboration (439)
Compensation (244)
COVID-19 (2537)
C-suite (106)
Data (1336)
Diabetes (161)
Diagnostics (6165)
Earnings (84863)
Employer resources (146)
Events (109893)
Executive appointments (356)
FDA (16718)
Funding (402)
Gene therapy (191)
GLP-1 (590)
Government (4330)
Healthcare (18683)
Infectious disease (2624)
Inflammatory bowel disease (109)
Interviews (308)
IPO (16321)
Job creations (3625)
Job search strategy (1417)
Layoffs (415)
Legal (7857)
Lung cancer (184)
Manufacturing (194)
Medical device (13204)
Medtech (13209)
Mergers & acquisitions (19168)
Metabolic disorders (427)
Neuroscience (1559)
NextGen Class of 2024 (6500)
Non-profit (4466)
Northern California (1623)
Obesity (248)
Opinion (180)
Patents (113)
People (56379)
Phase I (20070)
Phase II (28435)
Phase III (21201)
Pipeline (497)
Postmarket research (2559)
Preclinical (8534)
Radiopharmaceuticals (236)
Rare diseases (245)
Real estate (5890)
Regulatory (21611)
Research institute (2309)
Resumes & cover letters (349)
Southern California (1412)
Startups (3562)
United States (14583)
Vaccines (558)
Weight loss (175)
Date
Today (158)
Last 7 days (655)
Last 30 days (2928)
Last 365 days (35390)
2024 (34225)
2023 (40076)
2022 (51174)
2021 (55715)
2020 (54087)
2019 (46541)
2018 (35020)
2017 (32109)
2016 (31481)
2015 (37552)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29263)
2010 (27328)
Location
Africa (713)
Arizona (194)
Asia (37215)
Australia (6074)
California (3645)
Canada (1387)
China (285)
Colorado (165)
Connecticut (167)
Europe (79704)
Florida (506)
Georgia (128)
Illinois (367)
Indiana (215)
Kansas (96)
Maryland (612)
Massachusetts (2842)
Michigan (166)
Minnesota (283)
New Jersey (1050)
New York (1040)
North Carolina (727)
Northern California (1623)
Ohio (144)
Pennsylvania (892)
South America (1091)
Southern California (1412)
Texas (520)
Utah (105)
Washington State (384)
687,127 Results for "veristat inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Veristat Joins the Alliance for Regenerative Medicine (ARM) to Help Address Critical Issues Impacting the Advanced Therapy Sector
Veristat, the Science-First Full Service CRO and Consultancy, announced it has joined the Alliance for Regenerative Medicine (ARM), the leading international advocacy organization championing the benefits of cell and gene therapies for patients, healthcare systems, and society.
April 3, 2024
·
3 min read
Business
Veristat Taps Accomplished Industry Leaders to Support Growth and Innovation
Veristat, a scientific-minded global clinical research organization and regulatory consultancy, shared the addition of three seasoned leaders to Veristat’s Executive team.
May 23, 2023
·
4 min read
Policy
Veristat Congratulates HIPRA for EMA Approval of Its BIMERVAX® COVID-19 Vaccine
Veristat congratulated HIPRA for marketing authorization by the European Medicines Agency and European Commission of BIMERVAX®, a bivalent adjuvanted vaccine based on the Beta and Alpha variants of SARS-CoV-2 and indicated as a booster dose for people over 16 years of age.
April 25, 2023
·
3 min read
Policy
Veristat Supported Eight Regulatory Approvals in 2022, the Majority for Therapies Designed to Treat Rare Diseases
Veristat, a scientific-minded global clinical research organization (CRO), announced today that the Company supported clients in preparing marketing applications for eight therapies that received regulatory approval in 2022.
February 14, 2023
·
3 min read
Genetown
Veristat Presents Integrated, Customized DCT Solutions at the DTRA Annual Meeting
Offering integrated solutions for the implementation of decentralized clinical trials (DCTs), Veristat presented the advantages of its flexible and fully customized service delivery model at the Decentralized Trials Research Alliance (DTRA) annual meeting, which took place last month in Boston.
December 13, 2022
·
3 min read
Genetown
Veristat Joins Decentralized Trials & Research Alliance (DTRA) to Improve the Patient Experience
Veristat announced that it has joined an alliance of over 120 life sciences and healthcare organizations whose mission is to accelerate the broad adoption of patient-focused, decentralized clinical trials and research.
October 13, 2022
·
4 min read
Business
Veristat Appoints Joe Scott as Chief Financial Officer
Veristat, a scientific-minded global clinical research organization (CRO), announced the appointment of Joe Scott to the position of Chief Financial Officer
February 23, 2022
·
3 min read
Genetown
Veristat Expands its Expertise and Scale across Biopharma and Medtech
Veristat, a scientific-minded global clinical research organization, announced the expansion and strengthening of its service capabilities by acquiring SFL.
March 7, 2022
·
5 min read
Press Releases
ABS Bio, Inc. announces strategic investment by 3 Boomerang Capital
◆Investment to support services growth. ◆Industry veterans join board of directors, including John Chickosky as Executive Chairman, and Greg Swanberg and Martin LeBlanc as Directors.
November 14, 2024
·
1 min read
Press Releases
Poseida Therapeutics, Inc. Announces Agreement to be Acquired by Roche Holdings, Inc.
November 26, 2024
·
9 min read
1 of 68,713
Next
